| Literature DB >> 29233035 |
Andrea N García-Pérez1, Anne de Jong2, Sabryna Junker3, Dörte Becher3, Monika A Chlebowicz1, José C Duipmans4, Marcel F Jonkman4, Jan Maarten van Dijl1.
Abstract
Wound-colonizing microorganisms can form complex and dynamic polymicrobial communities where pathogens and commensals may co-exist, cooperate or compete with each other. The present study was aimed at identifying possible interactions between different bacteria isolated from the same chronic wound of a patient with the genetic blistering disease epidermolysis bullosa (EB). Specifically, this involved two different isolates of the human pathogen Staphylococcus aureus, and isolates of Bacillus thuringiensis and Klebsiella oxytoca. Particular focus was attributed to interactions of S. aureus with the two other species, because of the high staphylococcal prevalence among chronic wounds. Intriguingly, upon co-cultivation, none of the wound isolates inhibited each other's growth. Since the extracellular proteome of bacterial pathogens is a reservoir of virulence factors, the exoproteomes of the staphylococcal isolates in monoculture and co-culture with B. thuringiensis and K. oxytoca were characterized by Mass Spectrometry to explore the inherent relationships between these co-exisiting bacteria. This revealed a massive reduction in the number of staphylococcal exoproteins upon co-culturing with K. oxytoca or B. thuringiensis. Interestingly, this decrease was particularly evident for extracellular proteins with a predicted cytoplasmic localization, which were recently implicated in staphylococcal virulence and epidemiology. Furthermore, our exoproteome analysis uncovered potential cooperativity between the two different S. aureus isolates. Altogether, the observed exoproteome variations upon co-culturing are indicative of unprecedented adaptive mechanisms that set limits to the production of secreted staphylococcal virulence factors.Entities:
Keywords: Bacillus thuringiensis; Klebsiella oxytoca; Staphylococcus aureus; chronic wound; co-culture; exoproteome
Mesh:
Substances:
Year: 2018 PMID: 29233035 PMCID: PMC5955179 DOI: 10.1080/21505594.2017.1395129
Source DB: PubMed Journal: Virulence ISSN: 2150-5594 Impact factor: 5.882
Figure 1.Growth characteristics of the isolated bacteria on agar plates. (A) Microbiome topography of culturable bacteria from the wound dressing of a patient with Junctional EB. The used dressing from a chronic wound was replica plated onto CLED agar for isolation of the bacteria present. (B) Zone inhibition experiments. Unimpaired staphylococcal growth upon spotting of B. thuringiensis or K. oxytoca: (i) t111+Bt, (ii) t13595+Bt, (iii) t111+Ko, and (iv) t13595+Ko. Unimpaired growth of K. oxytoca upon spotting of B. thruingiensis (v). S. aureus growth inhibition halo caused by spotting of B. subtilis 168 onto a lawn of staphylococcal cells (vi; both S. aureus strains exhibited the same effect). (C) Dilution and subsequent plating: (i) S. aureus colonies growing on top of larger colonies of B. thuringiensis; (ii) K. oxytoca and S. aureus colonies growing in close proximity and occasionally touching each other. Typical S. aureus colonies are marked with arrows.
Figure 2.Total numbers of extracellular proteins identified per culture. (A) Numbers of S. aureus t111 and t13595 exoproteins identified in monocultures or upon co-culturing with B. thuringiensis (+Bt) or K. oxytoca (+Ko). (B) Numbers of B. thuringiensis and K. oxytoca exoproteins identified in monocultures or upon co-culturing with S. aureus t111 (+t111) or t13595 (+t13595) isolates. (C-F) Predicted subcellular localization of proteins per strain in mono- or co-cultures. (C) 11, S. aureus t111 exoproteins; 11B, S. aureus t111 exoproteins upon co-culture with B. thuringiensis; 11K, S. aureus t111 exoproteins upon co-culture with K. oxytoca. (D) 13, S. aureus t13595 exoproteins; 13B, S. aureus t13595 exoproteins upon co-cultures with B. thuringiensis; 13K, S. aureus t13595 exoproteins upon co-culture with K. oxytoca. (E) K, K. oxytoca exoproteins; K11, K. oxytoca exoproteins upon co-culture with S. aureus t111; K13, K. oxytoca exoproteins upon co-culture with S. aureus t13595. (F) B, B. thuringiensis exoproteins; B11, B. thuringiensis exoproteins upon co-culture with S. aureus t111; B13, B. thuringiensis exoproteins upon co-culture with S. aureus t13595.
Figure 3.Relationships among cultures. The diagrams show the number of proteins identified in all cultures and those proteins shared in the different conditions. (A) Total number of S. aureus t111 proteins in monoculture (11) and in co-culture with B. thuringiensis (11B) or K. oxytoca (11K); (B) Total number of S. aureus t13595 proteins in monoculture (13) and in co-culture with B. thuringiensis (13B) or K. oxytoca (13K); (C) Total number of B. thuringiensis proteins in monoculture (B) and in co-culture with S. aureus t111 (B11) or S. aureus t13595 (B13); (D) Total number of K. oxytoca proteins in monoculture (K) and in co-culture with S. aureus t111 (K11) or S. aureus t13595 (K13); (E) Total number of S. aureus proteins in monoculture (11) or (13) and in co-culture (11+13).
Figure 4.Overview of the predicted functions of the exoproteins found in all staphylococcal cultures. Diagram (A) depicts only S. aureus t111 proteins. The area on the top shows the proteins detected only in monoculture, while the lower left area shows a single protein detected when t111 was co-cultured with B. thuringiensis. Likewise, diagram (B) shows exclusively the proteins that belong to S. aureus t13595 in monoculture and co-culture with B. thuringiensis or K. oxytoca. Diagram (C) depicts the proteins of S. aureus t111 and t13595 grown in monoculture in the bottom areas, whilst the upper area shows the proteins identified upon co-culturing both S. aureus isolates. In the latter area, the circles are represented as pie charts. The charts show the percentage of proteins that belong to each isolate. For the unknown proteins (in grey), 50% belong to t111, 37% to t13595, and 12.5% to both of them; for the cell envelope proteins (blue) 67% belong to t111 and 33% to both isolates; for proteins involved in intermediary metabolism (green), 25% belong to t111 and 75% to t13595; and for information pathways proteins (yellow), 50% belong to t111 and 50% to both isolates.
Summary of differentially detected extracellular proteins among the different cultures. Volcano plots (Supplemental Figure S6) displayed P values (-log10) versus fold changes (log2) of the normalized spectral counts. Folds ≤1 represent proteins that were significantly up-regulated in the co-cultures and folds >1 represent proteins that were significantly up-regulated in monoculture.
| Species | Protein | Function / Gene ontology | Fold | p value |
|---|---|---|---|---|
| Beta-lactamase | Hydrolysis of beta-lactamic ring | 12.81 | 0.041 | |
| Phosphocarrier protein HPr | Phosphoenolpyruvate-dependent sugar phosphotransferase system. Serine/threonine kinase activity. Regulation of transcription, DNA-templated | 6.61 | 0.009 | |
| Fructose-bisphosphate aldolase class 1 | Glycolytic process | 12.89 | 0.042 | |
| Elongation factor Ts | Binds to aminoacyl-tRNA. Protein biosynthesis | 29 | 0.034 | |
| Triosephosphate isomerase | Gluconeogenesis. Glycolytic process. Pentose-phosphate shunt | 18 | 0.038 | |
| 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase | Gluconeogenesis. Glycolytic process | 16.80 | 0.048 | |
| Cysteine synthase | Cysteine biosynthetic process from serine | 13 | 0.045 | |
| Phosphate acetyltransferase | Acetyl-CoA biosynthetic process | 15.60 | 0.039 | |
| Thioredoxin reductase | Removal of superoxide radicals | 17 | 0.040 | |
| Putative universal stress protein SSP1056 | Response to stress | 13 | 0.046 | |
| D-alanine-poly(phosphoribitol) ligase subunit 2 | Cell wall organization. Lipoteichoic acid biosynthetic proces. Regulation of cell shape | 6 | 0.039 | |
| Uncharacterized protein | Unknown | 2.68 | 0.003 | |
| Colicin I receptor | Bacteriocin transport. Iron assimilaiton. Siderophore transmembrane activity | 1.63 | 0.036 | |
| Glyceraldehyde-3-phosphate dehydrogenase | Glucose metabolic process. Glycolytic process | 0.33 | 0.044 | |
| TonB-dependent hemin, ferrichrome receptor | Transporter activity | 1.79 | 0.024 | |
| Glutathione-binding protein GsiB | ABC transporter complex (periplasmic space) | 1.26 | 0.043 | |
| Phosphoglycerate kinase | ATP binding. Glycolytic process | 0.37 | 0.030 | |
| Glycine betaine-binding periplasmic protein | Transporter activity | 1.81 | 0.010 | |
| Protein TolB | Bacteriocin transport. Uptake of colicins (group A) | 1.50 | 0.029 | |
| Leucine-specific-binding protein | L-alpha-amino acid transmembrane transport. | 2.16 | 0.002 | |
| Pyruvate kinase I | Glycolysis. Magnesium, potassium and ATP-binding. | 0.23 | 0.038 | |
| Glutamine-binding periplasmic protein | Amino acid transport. | 1.49 | 0.040 | |
| 6-phosphogluconolactonase | Pentose phosphate pathway. | 0.5 | 0.022 | |
| Osmotically-inducible lipoprotein E | Possibly involved in maintaining the structural integrity of the cell envelope. | 4.75 | 0.002 | |
| Periplasmic serine endoprotease DegP | Degrades transiently denatured and unfolded proteins accumulated in the periplasm in stress conditions | 4.86 | 0.002 | |
| Uncharacterized protein | Unknown | 10 | 0.004 | |
| Periplasmic trehalase | Cellular hyperosmotic response | 3.60 | 0.049 | |
| Uncharacterized protein | Unknown | 6.67 | 0.011 | |
| Uncharacterized protein | Unknown | 0.13 | 0.031 | |
| Peptidoglycan-associated lipoprotein | Possibly bacterial envelope integrity | 3.20 | 0.019 | |
| Chaperone protein MrkB | Cell wall organization. Chaperone-mediated protein folding. Pilus organization. | 5.33 | 0.045 | |
| MltA-interacting protein | Peptidoglycan byosynthetic process | 24 | <0.001 | |
| Thiamine-binding periplasmic protein | ATP binding. Thiamine transport. | 8 | 0.010 | |
| Uncharacterized protein | Unknown | 14.61 | 0.001 | |
| Sulfatase | Sulfuric ester hydrolase activity | 3.59 | 0.008 | |
| Internalin | The function of this domain is not clear | 4.12 | <0.001 | |
| Endopeptidase lytE, putative lytE | The function of this domain is not clear | 2.08 | 0.023 | |
| Peptidase M4 thermolysin | The function of this domain is not clear | 2.70 | <0.001 | |
| Enolase | Glycolytic process | 4.44 | 0.043 | |
| Bacillolysin | Extracellular zinc metalloprotease | 4.40 | 0.002 | |
| Extracellular solute-binding protein family 5 | The function of this domain is not clear | 3.37 | 0.005 | |
| VanW | Vancomycin resistan protein W. The function is not clear. | 2.80 | 0.045 | |
| Uncharacterized protein | Unknown | 3.76 | 0.014 | |
| Uncharacterized protein | Unknown | 25 | <0.001 | |
| Uncharacterized protein | Unknown | 5.33 | 0.026 | |
| Uncharacterized protein | Unknown | 14 | 0.011 | |
| Oligopeptide transporter, periplasmic-binding protein | ABC transporter complex | 17 | 0.001 | |
| Periplasmic component of efflux system | Transmembrane transport | 18 | <0.001 | |
| Camelysin Metallo peptidase MEROPS family M73 | The function of this domain is not clear | 7.33 | 0.031 | |
| Flagellar hook-associated protein 3 | Bacterial-type flagellum-dependent cell motility | 11 | 0.014 | |
| Uncharacterized protein | Unknown | 10 | 0.035 | |
| Uncharacterized protein | Unknown | 8 | 0.010 | |
| Uncharacterized protein | Unknown | 7 | 0.021 | |
| Foldase protein PrsA 2 | Protein folding | 9 | 0.008 | |
| Glucose-specific phosphotransferase enzyme IIA component | Phosphoenolpyruvate-dependent sugar phosphotransferase system | 0.19 | 0.030 |